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Objecz$ves. The aim of this study was lo determiae the inei- 
dense and significance of second- or third-degree heart black 
among patients with inferior mywardist iniarction treated with 
‘bmmbLdyltc ixrapy. 
Bac@rund. Daba lram the prethmmbdytic era ruggegort that 
heart block occurs in approximately 20% of patients with acute 
inferior myocardial infarction and is mm&ted with a marked 
increase in mortality. Little is known about the incidence and 
pagnostic implications of bwt blwk amang patients receiving 
thmnbo~ir therapy. 
Merh0ds. We studied 1,186 patients with acute inlertor myo- 
e&ii i&r&n enrc&d in tb Tbmmbdysir in Myafardial 
InIarctioo (TIMI) II Trial who received rrrcmbinant issue-type 
plasminogen activatei @t-PA) within 4 b oltbe onset oisymptoms. 
IZcsuUr. Heart black wawred in 214 patients (12%): 113 
(6.3%) bad beasrt block on preve”t&n and ,ot(5.7%) developd 
heart block in the 24 b alter treatmnt with rt.P.4. patients airh 
beart block at erdrv were slilhtlv older and a ereater orwmrtttn 
bad cardiiic U&k. The s&y ma&lily r& ~m&g &ads 
with heart k&k at entry was 7.1% (8 of 113). compared with 
2.7% ,65 of 1,673) among pattentr wittut,‘ heart btock a‘ study 
entry (ret&e rkk 2.6, p = 0.01W. Hmvew- beati tdodr ps not 
of 39) of patients wba devdapcd bari block wnts 15.5% (112 of 
723) d patients ritbwt beart bbxk (p = 0.02). The Zl-day 
with imraed m&My. I’bw c&&4 aDd&tosdc dnts pip 
vide insight into the mecbaoti ol Msrt bk#k nod kwased 
mortality among such patient%. 
N An Co” ardiol1992;20:~3&~, 
Data fmm the prethrombalytic era reveal that high (second- 
orthird-) degree heart block occttrs in 19% ofpatients during 
acute inferior myocardial infarction (1). Altbougb !be heart 
block is generally responsive to medical therapy, it has been 
associated with a marked increase in mortality (I). This 
increased mortality appears to be due TV a iarger infarct size 
and greater impairment of left and right ventricular Function 
(2.3); however. rhe reason for the am&ion between the 
heart block and more extensive biventricular iofaretion is 
unclear. It is also unclear wbr’be, bcari block ~curring 
initmlly or later in the coarse of inferior myocardial infxc- 
tion is associated with increased morbidity and monality 
;4,5;. 
How thmmbolytic therapy aflects the incidents and 
prognostic implications of heart block complicating inferior 
infarction is unknown. Same iwestigaton have suggested 
that heart block after thmmbolytic lberapy may be a marker 
for successful reperfurion (6). Thus. one might expect heart 
block to OCEW more frequently after treatment with a 
thrombolytic agest. particularly in patients in whom reper- 
fusion is successSul. Conversely, because tbrombolytic ther- 
apy has been shown to decrease infarct size in inferior 
isfarctioa (7.8). -+iculzzly in patients witb a large amount 
of myocardium at risk (9.10). such therapy might be en- 
pected tc reduce the incidence of heart block and the high 
mortality rate associated with it. 
Accordingly, we performed B data bank analysis of 
patients enrolled in p’lase II of the Thrcmbolysis in 
Myocardial Infarction (TIMI) Trial to determme the inci- 
dence and prognostic implications of heart block com- 
plicating inferior myocardial infarction among patients 
treated with thrcmbclytic therapy. We sought to determine 
whether important differences exis: in heart block occurrirtg 
early and late in the course of inferior infarction. We also 
studied the anatomic correlates of heart block and the 
possibility that the development of heart block is a marker of 
reperfusion. 
Methods 
Inclusion criteria The TIM1 II inclusion criteria have 
previously been reported (II). Briefly, these criteria in- 
cluded age <76 years; 30 min of chest discomfort suggestive 
of acute myocardial ischemia; 20.1 mV ST segment eleva- 
tion in two contiguous leads; the feasibility of initiating 
treatment with recombinant issue-type plasmir;ogen activa- 
tor @t-PA) within 4 h of the onset of chest pain; and the 
patient’s consent. Exclusion criteria for TIM1 II included a 
history of cerebrovascu,ar disease. blood pressure 
>I80 mm Hg E!‘O!“!iC or 11n m* Hg diest*!ic, a b!eeding 
disorder, operatim within the previou 2 weeks, recent 
prolonged cardiopulmonary resuscitation, percutanecus 
transluminal coronary sngioplasty or severe trauma within 6 
months, prior cardiac surgery, left bundle branch block, 
dilated cardiomyopathy or other serious illness. 
All patients received rt-PA (150 mg ever 6 h in the first 
520 patients and 100 mg ever 6 h in the remaining 2.819 
patients) and were subsequently randomly assigned tc either 
cardiac catheterization followed by percutaneous translum- 
inal coronary angioplasty at 18 tc 48 h after treatment with 
rt-PA (invasive strategy) or to neither catheterization nor 
angioplasty (conservative strategy) unless ischemia devel- 
oped during the hospital stay despite medical therapy or was 
provoked during a predischarge xercise test. 
Eligible patients were randomly assigned to either imme- 
diate therapy with a beta-adrenergic blocking agent (intrave- 
nous metcprolol, three 5.mg injections at 2.min intervals 
followed by oral administration of 50 mg Nice a day on day 
I followed by 100 mg twice a day thereafter); or deferred 
beta-blocker therapy (oral metoprolol, 50 mg twice a day on 
day 6 and IO0 mg twice a day thereafter). Patients were 
excluded from randomization to immediate or deferred beta- 
block?dr if thpy were ~lnah!~ tc give infcrmed ccnsect. were 
already being treated with a beta-hlockcr. verapnmil or 
di!tiazem or had contraindicrations to betr.-b!ocker therapy, 
including a ventricular rate ~55 beatslmin, systohc blood 
pressure <9D mm Hg, moist r&s covering >H fmction of 
the lung fields, a~!hma, fir*t.degree heart black with a 
duration of >0.24 ms or higher degrees of atrioventricular 
(AV) block. The projeu protocol and consent forms were 
approved by the Institutional Review Boards of all partici- 
pating institutions. 
Study group. Patients with inferior infarction, defined 
as >O.l-mV ST segment elevation in ~1 lets! twc of the 
three inferior leads I!. 111 and aVF. were included in our 
xalyris. Patients with an implanted permanent pacemaker 
were excluded. Patienta were also excluded if myocardial 
infarction WBE not confirmed either by an elevation of 
creatine kinase to twice normal limits or by diagnostic 
changes on serial electrocardiograms (ECGs). Heart block 
at cntry was defined 3s second- or third-degree heart 
block present on admission: heart block by 24 h was defined 
as second- or third-degree heart block not present on admis- 
sion that occurred in the 1st 24 h after admission. The 
cccurrence of “eait ‘;l?ck after the 1st 24 h was not system- 
aticallv ramned is TIN II and is not considered in this 
report: 
Llala analysis. Right ventricular infarction was defined 
as the presence of a focal or diffuse right ventricular wall 
motion abnormality on predircharge rest radionuclide 
ventriculography. Only venlriculograms technically ade- 
quate in the anterior and left anterior oblique views, 
permitting accurate Gtalization of right ventricular wall 
motion, were incloded. The presence of multivwel disease, 
defined as a lesion ~60% in two or more major branches 
of the corcnary arteries, was evaluated in patients 
assigned tc the invasive strategy receiving protocol cardiac 
cathetenzation I8 to 48 h afterstudy entj.The presence of 
shock, defined as a systolic blood prewre real mm Hg 
with signs of peripheral hypoperfusio~ thought to he second- 
ary to cardiac dysfunction. was evaluated in each grcup. The 
presence of precordial ST segment depression, defined as 
a-mm horizontal or downsloping ST segment depression in 
at least two contiguous leads within leads V, through V,, 
was analyzed. The cause of death of each patient was 
determined by the Mortality and Morbidity Committee cfthe 
TIM1 Trial. 
Statistical analysis. The results presented iA this report 
are based on all hala processed in-the TIMI Ccordin&ng 
Center as of September 1990. All analyses were performed 
with either the SAS or BMDP programs (12.13). To adjust 
for the effects of multiple testing, D values between 0.01 and 
O.OOI were judged a; providi~g~same vidence of group 
differences, and p values < 0.001 were judged as providing 
strong evidence of group differences not due tc chance 
alone. Separate comparisons were made of patients with 
and without heart block before the initiation of r&PA therapy 
and (among patients free of heart block at entry) of pa- 
tients developing heart block in the 24 h after the initiation 
of thrcmbolytic therapy and those remaining free of 
heart block by 24 h. These separate analyses pmvided 
appropriate comparison groups tc examine 1) the impact 
of coronary anatomy and reprfusion past-thrombolytic 
therapy on the cccurrcn;e of heart block: 2) the impact 
of randomization to immediate intravesous beta-blocker 
lherapy versus deferred oral be@-blocker !herapy on the 
development of hear, block: 3) the chmcal presen,&ion 
a, study entry between patients with and with@“! heart 
block at study entry. or between ~a,ien,s who developed 
hear, block dy 24 h and patients’ who remained fro; of 
heart block at 24 h; and 4) the relative risk of monahty and 
@her adverse outcomes for patients with or without hean 
block a, study entry or bv 24 h after studv entry. Character- 
istics of patients with and without hean block were com- 
pared by using a Student t tesi and chl-rquare tests. Evect 
rates were computed 3y using the Kaplan-Mcier method and 
compared hy using the log-rank test statistic (I41 The Cox 
proponional hazards model was used ,o idenlify iodepen- 
dent varmbles that were associated rrith 21.day mortality 
(14). To avoid potential bias due 10 missmng data from 
patients who died or were otherwise unable to undergo a 
radionuclide study. comparisons of left ventricular function 
bv radionuclide ventriculography at hospital discharge 
within patient subgroups were compared on a composite end 
point defined by death within 21 days of srudy entry. failure 
to undergo radionuclide ventriculography within 21 days or 
rest ejection fraction <55%. Occurrence of this outcome was 
compared by “sing a chi-square test with I degree of 
freedom. 
RCSUllS 
Incidence of heart block. Of 1.786 palients with inferior 
VP. 16.2%. p = iW. The prevaleocc ofmuitive~rel disease 
infarction who met the inclusion criteria for this analysis. 214 
did no, differ belwrdn the two groups. Specifically, steooses 
(12%) developed second- or third-degree hear, block. Hean 
r6@% in both the left anterior descending and rhe right 
block was present at study entry before thrombolyhc ther- 
coronary anery were present in 16.4% (9 of 55) of padenrs 
spy in 113 patients (6.390. In the remaining 101 patients 
with heart block compared with 20.1% (149 of 740, p = NS) 
(5.7%). it developed within 24 h after initiiltion of n-PA 
of patients without heart block. The prevalence of hear, 
block ai entrv was similar amow oatients with and without 
therapy. left anterior descending zutery &ase (4.6% [9 of 197; vs. 
Heart Block ar Study Entry 
Lbeline characteristics (Table I). Clinical chax!eristirs 
of patients with and with-au, heart block at study entry are 
shown in Table 1. Parients with heart block a, enfry were 
slightly older and a gwa,er proportion had cardiogenic 
shock. They also had statistically (although not clinically) 
signiiicamly lower mean serum paassium levels than did 
patients without hean block. 
Anatomic data (Table 2). Amona patients assigned to the 
invasive strategy. protocol cardiaccatheterizationdata were 
available for 822 oatients: 59 t88.1%1 of 67 oatients with 
Table 2. Anaamic Data Obtained From Patients with and 
VAtho”, Flea* Wck a, Study Entry Who Underwent Promco, 
Coronary Angiography I8 to 48 Hours After Hospit& Admission 
heart block at study entry and 763 (S&S%) oE 840 patier.ts CnllaLcn! Ehanne:r p sent 9 ,,w 59,1x4, NT 
without heart block at study entry. Among these 822 pa- s,rnai,i a607 8” to!” the LAD ‘) ,,w, 119 w.1, NS 
tients. the right coronary artery was more commonly ,he md RCA 
infarct-related ansry in patients with than in patients without 
S,enasis al* in bolh Ihe LCX 9 ,16.4 137,1*.5, NS 
and RCA 
Table 3. Mortality. Ventr~ular Function and Pacemaker 
Placeme”, Among Panenu W,th and Wthout Hcan Black at 
Stud” Entrv 
7.1% 146 of 5981). Stenoses 3OC in both the left circumflex 
and right coronary arteries were present in a similar propor- 
tion of both groups. 
Clinical ccmrse (Table 3). The 21.day mortality rate was 
higher among patients with than amone those without heart 
block al study entry. Among patients who survived and 
underwent predischarge radionuclide ventriculography, 
there was no significant difference in ejection fraction on rest 
radionuclide ventriculography between the two groups. 
Right ventricular infarction on predischarge radionuclide 
ventriculoeraphy was present with similar frequency in both 
groups. Although approximately one third of patients with 
heat block a~ entry had a temporary pacemaker placed. no 
patient wth hean block underwent placement of a perma- 
nent pxcmzkcr. 
Etiology of death. Heart block WBS not listed BE the 
primary cau:c n!‘dc_‘b /ii any of the patierds with heart block 
at entry who died by 21 days: it was listed as a secondary 
cause in one patient with heart block. Pump failure was the 
primary or contributing EBUSC of death in 50% (4 of 8) of 
patients with heart block at sludy entry and in 3 I% (14 of 45) 
of patients without heart block at study entry. 
Multivariate analysis. Mulwariate analysis of variables 
o!! admission that pxdicted ?I-day mortality amuIag patients 
with inferior infarclion included the fallowing variables: 
heart block. age >70 yew, male gender. prw myocardial 
infarction, hypolension, atrial fibrillation. pulmonary edema 
or shock, history of diabetes mellims. use of beta-blockers 
before study entry and iovasive strategy. Only the presence 
of pulmonary edema or shock err admission was an indepen- 
dent predictor of morfaiity. 
Follow-up (Table 41. One-year nor&lily was not signiti- 
canlly different between Fatienrs with and without heart 
block at study entry. :fi addition. !herc was no diiierence 
between tile 1wo groups I” tile lncldrnce of recurrent myo- 
wdiai i&ztion or rrhospi&diwWn for angma or coo;es- 
tive heart failure. 
Table 4. Cardiac Events by 1 ‘iear After Study Entry Among 
Patients With and Wilbaut Heart Block at Studv Entrv 
Hem Block Developit:g After Initialion of 
Thrombolytia Therapy 
Baseline characteristics (Table 5). Baseline characteris- 
tics of patients surviving 24 h who did or did not develop 
heart black by 24 h are shown in Table 5. No significant 
differences were apparent in the clinical presentation at 
study entry of patients who did and did not develop heart 
block, except that a smaller proportion of patients with heart 
block by 24 h had prior angina and were receiving beta- 
blocker therapy before admission. 
E&et of immediale intravenous beta-bleaker therapy. 
Treatment with immediate intravenous beta-blockade did 
not signitcantly influence the likelihood of developing heart 
block. The incidence of hearc Liock was similar among 
patients randomized eilhcr to immediate intravenous meto- 
Table 5. Basctine Characteristics Among Patients Who Did and 
Did Not Develop Hran Block During the 24 Hours After 
Hcwital Admission 
prolol or to deferred ora! metoprolol begun on day 6 of the 
hospital stay (5.2% [ 18 of 3421 YE. 2.5% 19 of 3541. p = 0.061. 
Anatomic data (Table 6). Among patients free of heart 
block at study entry assigned to the invasive srrategy. 
protocol cardiac catheterization da;a ivcrz obtained for 39 
(51.2%) of48 patients developing heart block within 24 b of 
study entry. and for723 (91.3%) of792 patients without heart 
block by 24 h. Among these patients without protocol 
cardiac catheterization, 4 of 9 patients with heart block by 
24 h and 8 of 68 patients without heart block by 24 h died 
within 48 h of study entry. 
Anatomic data from prorccol catheterization among the 
39 patients who developed heart block and the 723 patients 
who had not developed heart block by 24 h after initiation of 
rt-PA therapy reveal that the right coronary artery was the 
infarct-related artery in 92.3% of patients (36 of 39) with 
heart block, and in 75.1% of patients (542 of 723) without 
heart block (p = 0.04). 
Occlusion of the infxt-related artery tended to be more 
common an,ong patients who developed heart block after 
initiation of rl-PA therapy than among patients without heart 
block by 24 h (28.2% [II of 391 vs. 15.5% 1112 of 7231, p = 
0.04). 
There vats no dilrence in the prevalence of multivessel 
disease between the two groups. Stenoses r&O% in bath the 
left anterior descending and the right coronary irtery were 
present in 26.3% (IO of 39) of patients who developed heun 
block cornoared with 19.8% (139 of 723) of patients who did 
iic: -‘-ec!;p L-” b!.xk :p = XS;. ::iat ::xk developed in 
B similar proportion of patients with (5.9% [II of 1881) and 
wilhoui (4.G i27 qf 5521) left anterior descending artery 
disease. Left circumflex artery diseasr was present in 15.8% 
(6 of 38) of patients with heart block by 24 h compared with 
35.3%1248 of702) ofpatients without heart block (p = 0.01). 
Cl&al ccwsz (Table ‘II. The 21.dav monalitv raw was 
greater among patients who did than among those who did 
not develoo heart block (9.% versus 2.2%. o < OSBII. The 
proponion’of patients wiih en ejection free& >55% on rest 
radionuclide ventriculography did not differ between the two 
groups (: = 0.10). There was a treud toward more irequent 
nght ventricul;: infarction on Prediacharge radionuclidr 
ventriculography among patients whodeveloped heart block 
after initiation of r&PA therapy. Almost 36% of patients who 
developed heart block after initiation of R-PA had 2 temw 
wry pacemaker placed, compared with 6.5% ofpatients who 
did not develop hean block. NO oatient with but four 
patients withouihean block by 24 h uidenvent placement of 
a permanent pacemaker. 
Etiotogy of&lb. Heart block was not listed as a primary 
or contributing cause of death in any of the patients who 
developed heat block after r&PA therapy. Pump failure was 
the primary orcontributingcause ofdeath in 4%(4 of IO) of 
the patients with heart block, similar to the 29% (IO of 35) of 
deaths due to pump failure among patients without heart 
block. 
Multivariate analysis. Multivariate anaiysis with the Cox 
proportional hazards model was used to determine whether 
development of heart block within the 1st 24 h was an 
independent predictor of ZI-day mortality among patients 
free of heart block at study entry. Other predictors consid- 
ered included age 270 years. gender. prior myoardial 
infarction, hypateusion, atriai 6brrllation. history of diabetes 
mellitus. oulmomw edema or shock at study entry. use of 
beta-blockers hefo; study entry, treatment &leg; and the 
debeiupurui &shock during the 1st 24 h. After adjustment 
for these factors, a trend existed toward increased martalitv 
among patieoltr with fiew bent? block (relative risk = 2.4, 
99% confidence interval 0.8 to 6 8, p = 0.03), although it did 
not meet study criteria for statistic& si@iicauce 
among panems with high degree heart block war 24%. in 
contrast o the Y% mortality rate among patients without heart 
block (I). The etiology of the increased mortality among 
patients with hean block in these studies appears to have been 
related to greater infarct size as well (2.3). 
Tha Tbmmbolysir and Aog;oplasty in Acute Myocardial 
Infarction (TAMI) investigators (IS) have reported on the 
outcome of 50 (13.4%) of 373 patients with complete heart 
block eurolled in the first four TAMI trials, iii which six 
:bromba!y:ic regimens were used sad invasive veisis cot 
servative angioplasty strategies were examined. Heart block 
occurred in 27 patients (7.2%) before and in 23 patients 
(6.2%) in the 24 h after thrombolytic therapy. The hean 
block was of brief duration (cl2 h) in 75% of the TAM1 
patients and lasted a median of only 2.5 h. Despite the brief 
duration of the heart block, patients with heart block had 
more in-hospital complications, including ventricular tachy- 
cardia and fibrillation, congestive heart failure, pulmonary 
edema and hypotension. The mortality rate among patients 
with heart block was 20% compared with 4% among patients 
without complete heart block. Althoo8h the TAM1 investi- 
gators considered only patients with third-degree heart block 
in their analysis, and patients with both second- and third- 
degree hart block were included for analysis in our study. 
the greater morbidity and mortaliiy among patients with 
hear! block in the TAM1 trials is in agreement with the 
results of OUT study. 
Etiology of heart block during inferior infarction. The 
exact cause of hean block in patients with inferior infarction 
is unknown. Traditionally it has been hypothesized that 
heart block during inferior infarction is due to the Bezold- 
Jarisch reflex, an outpouring of vagal stimuli resulting from 
the stimulation by ischemia of a&rent nerves in the area 
around the AV node. However, several studies have shown 
that reperfusion of the right coronary artery after the admin- 
istration of thrombolytic agents is also a strong stimulus of 
the Bezold-Iarisch reflex (16.17). If the preceding hypolhesis 
is correct, one would expect an increased incidence of hru 
block in patients receiving thrombolytic therapy. In fact, 
although patency of the infarct-related artery was dmu- 
mented in 85% of our patients undergoing catheterization 18 
to 48 h after admission, heart block developed in only 5% of 
patients surviving 24 h after r&PA therapy. This rate is 
similar to the 4% rate of development of heart block in the 
24 h after admission in the prethrombolytic era (I). !n 
addition, heart block in our study was associated with 
occlusion, not patency. of the infarct-related artery on 
catheterization 18 to 48 h aHer thrnmholytic therapy. On the 
basis of these data, it appear: that reperfosion is not asso- 
ciated with the development of heart block dorio inferior 
i_f&Ktioa tC-a$ :itL-: a d&t X;ihGiSs or riimulation 
of the Bxold-Jari& i&e_,. 
Followvp (Table 8). In the year after infarction. the 
mortality rate of patients with late heart block was signifi- 
cantly greater than that of patients without heart block (p = 
3.001). There was no difference between the two groups in 
the incidence of recurrent myocardial infarction or rebospi- 
talization for angina or congestive heart failure. 
Discussion 
Incidence and prognostic implicalions of heart block. In 
ihe cuxtrst study, heart block wes present at study entry in 
6.3% of patients and developed in an additional 5.7% of 
patients during the 24 h after initiation of thrombolytic 
therapy. Pooled data from the prethromholytic era reveal 
that high degree heart block was present on admission in 8% 
of patients with acute inferior infarction and occurred within 
24 h in an additional 4% of patients (IL Therefore, heart 
block remains a frequent complication in such patients. 
The ovemll 3% 21dav mortalitv rate in our study. was 
lower than that reported-tier infeior infarction in the pre- 
thrombolytic era. However, this rate was 2.7% among patients 
without heart block on study entry. 7.1% among patients with 
heart block an study entry and 9.9% among patients who 
developed heart block by 24 h after study entry. The relative 
risk of monality of patients with heart block on study entry 
compared with the risk of those without it, 2.6. and of patients 
who developed heart hhxk within 24 h of admissie,l &mpared 
with the risk of those who did not. 4.5, remains high. This 
increased mortality is somewhat perplexing in view of tie short 
duration of the heart block and its responsiveness to medical 
ihempy. Indeed, very few patients were believed to have died 
from the hezut block itselforfmm treatment of the hean block. 
The cau~s of death assigned by the Mortality and Morbidity 
Committee and the rerol!s of the multivaria~e analysis suggest 
that the heart block itself was not responsible for the increased ,. 
motity; rather, d prouded r&rer! e~+~. __ ..._._l__l ,.a ,,F :nr.s..sA 
lafarct size in such patients, as saPeested by the reduced 
importance of heart block when sh&iwas iricluded in multi- 
vitc d&j& The* data :;ii;tiag an rr,;rea& motii:y 
among patients with heert block are in agreement with pooled . 
aaa iror7i tnc prctnmnu.o,yt,c era. m UlhlCh the monabty rate cause of hear7 block during inferior infarction (iSi. it has 
been well demonstrated that septal perloratorr orlginatmg 
from the left anterior descending artery provide a rich 
network of collaterrd blood vessels to the AV node artery. 
which arises from the di:tal right coronary artery as it bend, 
:o eoursc along the crux of the heart. Bassan et al. 118,. m II 
study of 51 padents with inferior mfarction. I I of rrhom 
developed heart block. found that the development of hsart 
block had a nredictive value of 914 for concomitant left 
ant&or descending artery dtsease. Our data do not support 
this finding and in fact reveal that hear: block dturing inferior 
infarction is not asxxiated with concomitant left anterior 
descending anery disease. The mctdence of left aaterlor 
descending artery disease proximally or at any site was iou 
and war similar among patients with and without hean 
block. No diITerences were found in the proponto” of 
patients with and without heart block who had collateral 
channels IO the infarct-related artery. Other causes of 
heart block including hyperkalemia and treatment with 
beta-blockers, calcium channel blockers, glycoaides znd 
antiarrhythmic agents were present wth sinutar or even 
lesser frequency among patients who developed heart 
block than among those in whom heart block did not 
occur. Therefore, our study doer not permit a conclcsion 
about the exact cause of heart block in !bese patients. 
Immediate beta-adrenerglc blockade was associated with 
a trend toward an increased occurrence of heart block: this 
was presumably a direct effect of intravenous beta-blacker 
therapy, which is well known to cause prolongation of AV 
conduction. 
Possible explaaaIions for Ihe increased q orI& zxaci~t& 
with heart hlaek. As in previous studies, our data indicated 
that heart block was a marker for larger infarct size. They 
sugges!ed that among survivors of inferior infarctiun. ri&t 
ventricular infarction tended to occur more frequently 
among patients with heart block. Althotign left ventricutar 
function was similar among survivors in both groups, more 
patients with than without heart block died before undergo- 
ing radionuclide ventriculography. The results also suggest 
that patients with heart block had mcxe extensive left 
ventricular infarction and did not dk as 3 result of the heart 
block itself. In u multivariate analysts (r. predictors of 21.day 
mortality, only cardiogenic shock and pulmonary edema. not 
heart block, were found to be independent predictax of 
mortaiity. Although no deaths were seen after dtxharge 
among patients who had heart biock before thrombolytic 
therapy, the finding that patients who developed heart 
Mock after r&PA therapy hd i!xr?=ed aortdity in the year 
after hospital discharge is of concern. Because ief! ventric- 
ular function was similar antone survivors with and without 
howtal %w did so before undergoing vsntriculography and 
thus are not included in the analyses of left and &I 
ventr~olarfunction. Becaure uatients with hean block had a 
slgnilicantly greater in-hapilal mortality rate than did there 
witnout hean block, aA most of the deaths were a recult of 
pump faallurc. it is porsibic :hat a greater difference in 
ventricular function existed between the two groups than ~vie 
are able to demonstrate among survivors. The true incidence 
of right ientr~ttlx mfarct~on cannot be &mated. .?>d thus 
the mcidcncc awmg patients iii& SC::: b!ock is Z!S likely 
lo be an underestimation. Furthermore. II cannot be deter- 
muted exactly how many patients tn the trial had second- 
degree versus third-degree heat block. Results from prior 
studies suggest that both second- and third-degree heart 
block are asociated with increased mortality and that 
third-degree heart block is associated with a higher mortality 
rate than is second-degree heart block (I). Comparisons OF 
coronary anatomy among patients who did and did not 
deveiup Leart bkxk ;II iirb stud) need to be interpreted with 
cautron because of the higher percentage of patients who 
dcvctopcd heart block for whom angiogrdphic d&d wre not 
avadable. 
Can&siom. Heart block occurs frequently among pa- 
tients with inferior infarction and appears to be a marker fur 
gr.%er mferct size and increased mortality. The right coro- 
nary artery il mure often thr inlarct-related artery among 
patients wilh Ih?n wthout heart block. Occlusion of rhe 
inhrct-related artery tends to be present more frequently in 
patients wtth than arnon~ patients without heart block after 
treatment wth r&PA. Because reperfusion has been found to 
stimulate the Bezold-JarIsch reflex. this reflex is unlikely to 
contribute Ggnilicantly to the development of heart block. 
The prevalence cf multivessel disease is simiar emong 
patients with and without heart block. Althcugh the nwtal- 
ity rate of patients with heart block after thrombolyttc 
therapy is lower than that of historical cuntrol subjects, the 
relative risk of monality associated with heart block (2.6 for 
heart block on study entry. 4.5 for heart block in the 24 h 
after tbrombolytic therapy) remains elevated. Follow-up 
data suggest that mortality I year after discharge is increased 
in patients in whom heart block develops by 24 h after 
thrombolytrc therapy hut is not incrwed in patients 
rvho hr.ve heart block before receiving thrombolytic 
therapy. Further studies are needed IO determine the exact 
eausc of heart hlak commonly associated with inferior 
infarction. 
heart block. the westion arise; whether heart block might 
have recurreo and contributed to the increased mortalitv in References 
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